drugset / Trial / NCT00895583

Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

NCT00895583

Phase 4 Completed 254 enrolled Pfizer
RandomizedParallel-groupOpen-labelPrevention

Summary

This study will look at the effect on long-term kidney function using tacrolimus right after a transplant and then switching to sirolimus at 3 to 5 months after the transplant.

Timeline

Start
2009-06
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule Oral
Comparator Tacrolimus Small molecule

Indications